5.80
-0.20 (-3.33%)
| 前收盘价格 | 6.00 |
| 收盘价格 | 5.78 |
| 成交量 | 84,980 |
| 平均成交量 (3个月) | 82,810 |
| 市值 | 126,104,208 |
| 预期市盈率 (P/E Forward) | 26.88 |
| 价格/销量 (P/S) | 11.51 |
| 股市价格/股市净资产 (P/B) | 3.69 |
| 52周波幅 | |
| 利润日期 | 31 Mar 2026 |
| 营业利益率 (TTM) | -125.87% |
| 稀释每股收益 (EPS TTM) | -1.28 |
| 总债务/股东权益 (D/E MRQ) | 2.20% |
| 流动比率 (MRQ) | 17.14 |
| 营业现金流 (OCF TTM) | -7.33 M |
| 杠杆自由现金流 (LFCF TTM) | -4.74 M |
| 资产报酬率 (ROA TTM) | -26.73% |
| 股东权益报酬率 (ROE TTM) | -56.80% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Alpha Cognition Inc. | 看跌 | - |
AIStockmoo 评分
| 分析师共识 | 1.5 |
| 内部交易活动 | 3.5 |
| 价格波动 | 1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | 1.30 |
|
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease, for which there are limited or no treatment options. The Company’s current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company’s commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 11.04% |
| 机构持股比例 | 44.14% |
| 52周波幅 | ||
| 中 | 18.00 (210.35%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 19 Dec 2025 | 18.00 (210.34%) | 购买 | 5.56 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 5.80 | - | 142,308 | 821,316 |
| 累积净数量 | 142,308 | |||
| 累积净值 ($) | 821,316 | |||
| 累积平均购买 ($) | 5.80 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 09 Mar 2026 | 买 (+) | 2,179 | 5.87 | 12,791 | |
| OPALEYE MANAGEMENT INC. | 06 Mar 2026 | 买 (+) | 1,900 | 5.79 | 11,001 | |
| OPALEYE MANAGEMENT INC. | 05 Mar 2026 | 买 (+) | 47,023 | 5.74 | 269,912 | |
| OPALEYE MANAGEMENT INC. | 04 Mar 2026 | 买 (+) | 19,795 | 5.86 | 115,999 | |
| OPALEYE MANAGEMENT INC. | 03 Mar 2026 | 买 (+) | 51,411 | 5.75 | 295,613 | |
| OPALEYE MANAGEMENT INC. | 02 Mar 2026 | 买 (+) | 20,000 | 5.80 | 116,000 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合